TGFB1 and idiopathic pulmonary fibrosis: Ongoing research regarding its role in suppressing inflammation11, inducing apoptosis and suppressing tumor growth12 in parallel to inhibiting TGFβ1 signaling8, makes it a good therapeutic candidate for IPF patients.